The present study revealed that FGF21 levels were increased in the serum of stroke patients as well as in an experimental tMCAO mouse model and that glial cells such as microglia and astrocytes are another source of cerebral FGF21 after stroke in addition to neurons. This evidence concerns the gene FGF21 and Stroke.